We drop 2.39% they drop 4.2% on the day after the deal broke down. Given where they started, the shareholders there have to be thrilled with the whole outcome, there are now countless more eyes on their stock and company than before, and their stock is about 50% higher than before TW went public.
They are wearing me down, it's almost like the lock they have on this is more than longs can fight, so I go back to my earlier statements about nothing meaningful will happen here until the Company reports good news on their upcoming catalysts in trials. Almost nothing else matters. Even a CMO announcement may ignite a short term rally, but it wouldn't last, just like the MD Anderson collaboration, or Vince Milano buying 200,000 shares at $4.00, we are still way below that and nothing else matters.
Your educated guess is universally accepted in a 5 point rating scale. As a 3, that's almost like why bother, if I made my investment decisions on ratings like this, that would be crazy. No matter, it won't affect us unless they and others move their ratings further up the scale.
Given the circumstances, all of us have to do what's in our best interests, when they all go down together as often happens, the pressure valve needs to be released. Good fills both!
Tomorrow and into next week, this may have been the final capitulation of weak hands as they say. Either management gives us something positive next week or we head back down.
Today's low 4.66, currently trading at 4.82 and as high as 4.85, if we close green that would potentially mark the bottom of this leg and we either consolidate in here for a bit or we go back up toward the $5 mark and depending on earnings, we'll see huh?
"this is going to 3" if you really believe that you'd save the difference by selling and taking your lumps? For owning shares here, this is as close to bashing as they come.
Regenerative Medicine - The APAC Overview
The Asia-Pacific stem cell market was valued at US $7.10 billion in 2014 and is projected to increase to US $18.71 billion by 2018 at a CAGR of 27.3% for the period.
Sanjeev Kumar, Consultant, Growth Partnership Services, Healthcare, Frost & Sullivan, Asia Pacific attributes the positive growth in APAC to strong support from the industry.
Research firm Decision Resources anticipates the cancer immuno-therapy market in the U.S. could grow by nearly 24% per year between 2012 and 2022 to roughly $9 billion. If so, this represents a big opportunity for Caladruis, which could potentially draw the attention of a larger suitor that's pining for growth.
Omer chart looks compelling for an entry point, made money there before, good mention--thanks. What is your take on the day's carnage in biotech? Isolated action, or the weakening of our trend?
newbie, so far for me this has been a sideways add and hold, from first purchase back in March 2014. I've stubbornly persisted through the volatility, and wonder why I've not traded for the occasional profits I've had here. The answer to that is I have set goals for IDRA as a long term investment, is it more of a trading stock is the question?
rlb, sorry to hear how deep your losses have run, balanced by some of your gainers and your real estate activity you're still very well I'm sure, but avoiding this kind of stock in the future is as important as picking winners. I'm holding a small loss by comparison, but it is now 13.5%. I did add a small lot to my position yesterday, could have saved myself .20 had I waited. The filing today means more shares are being sold by holders, or shorted, your read?
At this price it had better outperform, like which direction is up from here, there's no electricity in this basement? Seriously, I know smart people that have this at $8-10/share and are holding it believing it will recover, you may be one of them? Buy low remember?
Nevertheless, at this price 5.17 it has a lot of failure built into it, so the risk reward is actually very good. I added another lot today at 5.17, holding now 4,500 shares at 5.72. I think I'll do well with it at this entry level. Good luck all.
CLBS, you can do it, it's okay if you go up, green is good, that's it, see! One cannot predict the absolute timing, that's where we get it wrong, being right the idea and right the timing is the goal. I was early, most all of us were early, so now as the idea adjusts to the timing, we'll start to get back our green. Good luck people!
Sentiment: Strong Buy
It's good for the stock and holders to have some distribution in here, have to build a base for this tower or it becomes unstable. 15% is about right, to where it was on Friday, let some more people in at a reasonable level, and once it rests a few days, take it on up to new highs.
Rus, already the ranks have closed and yet your voice is still here? Not uncommon to check back and see what your old friends are doing. The day you sold was good timing, if you had wanted back in you could have saved 10% on the re-buy-in. Good luck in EYES.